1. Home
  2. Analysis
  3. Loraz
  4. Darzalex-faspro

Loraz and Darzalex faspro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Darzalex faspro (daratumumab;hyaluronidase-fihj). Common drug interactions include fatigue among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Darzalex faspro. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Darzalex faspro?

Darzalex faspro has active ingredients of daratumumab;hyaluronidase-fihj. eHealthMe is studying from 1,741 Darzalex faspro users. Check the latest studies of Darzalex faspro.

On Jul, 21, 2026

19 people who take Loraz and Darzalex faspro together, and have interactions are studied.

Loraz and Darzalex faspro drug interactions.

What are the common drug interactions of Loraz and Darzalex Faspro, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Rash
  3. Erythema (redness of the skin)
  4. Anaemia (lack of blood)
  5. Arthralgia (joint pain)
  6. Constipation
  7. Cough
  8. Diarrhoea
  9. Dizziness
  10. Drug ineffective

male:

  1. Fatigue (feeling of tiredness)
  2. Weight decreased
  3. Rash
  4. Sensory disturbance (sense disturbance)
  5. Skin tightness
  6. Visual impairment
  7. Asthenia (weakness)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Diarrhoea
  10. Dry skin

What are the common drug interactions of Loraz and Darzalex Faspro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Weight decreased
  2. Constipation
  3. Diarrhoea
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Rash
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Uveitis (inflammation of the uvea)
  8. Weight increased

60+:

  1. Fatigue (feeling of tiredness)
  2. Rash
  3. Drug ineffective
  4. Dry skin
  5. Dyspnoea (difficult or laboured respiration)
  6. Gastric disorder (disease of stomach)
  7. Memory impairment
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Neuropathy peripheral (surface nerve damage)
  10. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 18 people, 94.74%
  2. Muscle Spasms (muscle contraction): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Darzalex faspro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Darzalex faspro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Darzalex faspro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Darzalex faspro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and daratumumab;hyaluronidase-fihj (the active ingredients of Loraz and Darzalex faspro, respectively), and Loraz and Darzalex faspro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.